CSO’s submits NGO draft IRR to DOH and IPO

Posted on January 26, 2009. Filed under: News |

On Sept. 4, 2008, Civil Society Organizations conducted a press conference at Max’s, Ma. Orosa cor. U.N. to submit the draft NGO Implementing Rules and Regulations on R.A. 9502 to Dept. of Health and the Intellectual Property Office.
——
AGAP Statement

We at AYOS NA GAMOT SA ABOT-KAYANG PRESYO (AGAP), a multi-sectoral coalition made up of health professionals, labor union activists, civil society organizations, consumer groups and public health workers, is one with the rest of the access to medicines advocates in submitting the NGO’s Implementing Rules and Regulations to the Department of Health and Intellectual Property Office for their consideration in the crafting of the IRR of R. A. 9502 or the Universally Accessible Cheaper and Quality Medicines Act of 2008.

We are happy that finally a law is in place that will serve to protect public health. The measure will surely bring down the prices of medicines in the country brought about by provisions that will create meaningful competition in the pharmaceutical industry such as compulsory licensing, parallel importation and the ‘early-working’ conditions or Bolar provisions. We are hopeful that this new law will be effectively implemented to achieve its desired result of bringing greater access of medicines to the Filipino people.

We, nevertheless, would like to strongly challenge the DOH to adhere to the law’s declaration that the drug price monitoring provision be implemented only when full market competition does not work, making said provision a reserve measure.

We also call for a reiteration in the IRR of the exclusion from patent protection of frivolous inventions as this is contrary to public policy, causing public harm since it prolongs the life of a patented product when generic competition could have been already introduced at an earlier date, again, encouraging meaningful competition.

Finally, we urge the government to involve the civil society in the implementation of this measure such as in monitoring drug prices as part of consultative bodies/councils, partners in generics information campaign, among others.

The campaign for greater access to medicines does not end here. AGAP will continue to monitor the effects of the law’s implementation, support the bill seeking to strengthen the Bureau of Food and Drugs (BFAD) now pending in both houses of Congress, advocate for a Universal Health Coverage System (Strengthening Philhealth) and conduct information dissemination campaigns on affordable and quality medicines and public health to the different sectors of the society.

Text of NGO Draft Implementing Rules and Regulations
Intellectual Property Provisions
All other Provisions

See Related Articles:

NGOs urge transparency in IRR crafting of Cheaper Medicines Bill
One-to-one generic-branded drugs ratio pushed

Advertisements

Make a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: